By altering the mRNA structure, researchers can create stable, non-immunogenic mRNA through in vitro transcription.

Nanoparticles have once again reached the spotlight, this time as a critical tool to combat the spread of covid-19. In this ...

For mRNA decapping by enhancing DCP2's mRNA-binding affinity and regulating distinct biological processes through DCP1a and DCP1b, human DCP1 is essential.

Moderna (MRNA) stock gains as company posts better than expected Q3 results driven by its updated COVID-19 vaccine. Read more ...

Brad Miller, Moderna's CIO, has driven technology innovation to help drive continued gains for the roughly $7 billion revenue ...

Moderna Chief Human Resources Officer Tracey Franklin has expanded her role to Chief People and Digital Technology Officer, overseeing the Company's talent and digital functions. Brad Miller, Chief ...

And this is precisely where the scientists's new strategy comes in. Based on the structure of the mRNA-binding protein, they have developed a large peptide, that can block the interaction of the ...

And this is precisely where the scientists' new strategy comes in. Based on the structure of the mRNA-binding protein, they have developed a large peptide that can block the interaction of the ...

Good afternoon, ladies and gentlemen, and welcome, everyone, to the Maravai LifeSciences Third Quarter 2024 Earnings Conference Call. All lines have been placed on mute to prevent any background noise ...

This important manuscript provides insights into the competition between Splicing Factor 1 (SF1) and Quaking (QKI) for binding at the ACUAA branch point sequence in a model intron, regulating exon ...

All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and ...